Roche Holding AG

Pharmaceuticals
ROG.SW
CHF 231 (0.41)%
Share price
$ 211 bn
Market Cap
$ 237 bn
Enterprise Value

Carbon footprint

1.5 Ton
GHG emissions per $ 1 mln investment
0.05x the weighted average for S&P 500
FY2022
How is this calculated?
-14%
YOY change in GHG emissions
Stronger than the -11% weighted average for S&P 500
FY2022 vs. previous year

Primary Climate Goal

-8.9%
Proj. YOY change in GHG emissions (Scope 1 + 2)
In line with the -9.3% weighted average for S&P 500
FY2023
How is this calculated?

Roche Holding AG aims to reduce Scope 1 + 2 by 40% by 2025 from a base year 2020


This target has not been verified as science based according to SBTi
Roche Holding AG's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Roche Holding AG's GHG emissions (market-based) (Kt of CO2e)
Roche Holding AG's Carbon intensity (Tons per 1 USDm)

Roche Holding AG's carbon footprint

Roche Holding AG reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2022 at 364 Kt (-58 /-13.8% y-o-y). Also positively, carbon intensity was down at 5.2 t (-0.7 /-11.9% y-o-y).

Roche Holding AG's Scope 3 emissions decreased sharply to 4,551 Kt (-3,348 /-42.4% y-o-y). There has been no consistent trend in recent years.

The company is committed to reducing Scope 1 + 2 by 40% by 2025 from a base year 2020, which translates into the estimated reduction of -32 Kt per annum over the period of FY2023 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...
Copyright © 2024 Exerica. All rights reserved.